Dosing regimens associated with extended release paliperidone injectable formulations
US12208100B2 · kind B2 · utility
0Cited by
11References
25Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 6, 2022 |
| Grant date | Jan 28, 2025 |
| Priority date | — |
| Expiry date | May 6, 2042 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P25/24
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides a method of treating patients with long acting injectable paliperidone palmitate formulations.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.